
According to this study, the global In-situ Hybridization (ISH) market size will reach US$ million by 2030.
In situ hybridization (ISH) is a type of hybridization that uses a labeled complementary DNA, RNA or modified nucleic acids strand (i.e., probe) to localize a specific DNA or RNA sequence in a portion or section of tissue (in situ), or, if the tissue is small enough (e.g., plant seeds, Drosophila embryos), in the entire tissue (whole mount ISH), in cells, and in circulating tumor cells (CTCs).
In situ hybridization is used to reveal the location of specific nucleic acid sequences on chromosomes or in tissues, a crucial step for understanding the organization, regulation, and function of genes. The key techniques currently in use include: in situ hybridization to mRNA with oligonucleotide and RNA probes (both radio-labelled and hapten-labelled); analysis with light and electron microscopes; whole mount in situ hybridization; double detection of RNAs and RNA plus protein; and fluorescent in situ hybridization to detect chromosomal sequences. DNA ISH can be used to determine the structure of chromosomes. Fluorescent DNA ISH (FISH) can, for example, be used in medical diagnostics to assess chromosomal integrity. RNA ISH (RNA in situ hybridization) is used to measure and localize RNAs (mRNAs, lncRNAs, and miRNAs) within tissue sections, cells, whole mounts, and circulating tumor cells (CTCs).
This report presents a comprehensive overview, market shares, and growth opportunities of In-situ Hybridization (ISH) market by product type, application, key players and key regions and countries.
Segmentation by product type:
Fluorescence In Situ Hybridization (FISH)
Chromogenic In Situ Hybridization
Segmentation by Application:
Molecular Diagnostic Laboratories
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Academic & Research Institutions
This report also splits the market by region:
United States
China
Europe
Other regions:
Japan
South Korea
Southeast Asia
Rest of world
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
ABBott Laboratories
F.Hoffmann-La Roche
Thermofisher Scientific
Merck
Agilent Technologies
Perkin Elmer
Danaher Corporation
Exiqon
Biogenex Laboratories
Advanced Cell Diagnostics
Bio SB
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global In-situ Hybridization (ISH) Market Size 2024-2030
2.1.2 In-situ Hybridization (ISH) Market Size CAGR by Region
2.2 In-situ Hybridization (ISH) Segment by Type
2.2.1 Fluorescence In Situ Hybridization (FISH)
2.2.2 Chromogenic In Situ Hybridization
2.3 In-situ Hybridization (ISH) Market Size by Type
2.3.1 Global In-situ Hybridization (ISH) Market Size Market Share by Type (2024-2030)
2.3.2 Global In-situ Hybridization (ISH) Market Size Growth Rate by Type (2024-2030)
2.4 In-situ Hybridization (ISH) Segment by Application
2.4.1 Molecular Diagnostic Laboratories
2.4.2 Pharmaceutical & Biotechnology Companies
2.4.3 Contract Research Organizations (CROs)
2.4.4 Academic & Research Institutions
2.5 In-situ Hybridization (ISH) Market Size by Application
2.5.1 Global In-situ Hybridization (ISH) Market Size Market Share by Application (2024-2030)
2.5.2 Global In-situ Hybridization (ISH) Market Size Growth Rate by Application (2024-2030)
3 In-situ Hybridization (ISH) Key Players
3.1 Date of Key Players Enter into In-situ Hybridization (ISH)
3.2 Key Players In-situ Hybridization (ISH) Product Offered
3.3 Key Players In-situ Hybridization (ISH) Funding/Investment Analysis
3.4 Funding/Investment
3.4.1 Funding/Investment by Regions
3.4.2 Funding/Investment by End-Industry
3.5 Key Players In-situ Hybridization (ISH) Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions
4 In-situ Hybridization (ISH) by Regions
4.1 In-situ Hybridization (ISH) Market Size by Regions (2024-2030)
4.2 United States In-situ Hybridization (ISH) Market Size Growth (2024-2030)
4.3 China In-situ Hybridization (ISH) Market Size Growth (2024-2030)
4.4 Europe In-situ Hybridization (ISH) Market Size Growth (2024-2030)
4.5 Rest of World In-situ Hybridization (ISH) Market Size Growth (2024-2030)
5 United States
5.1 United States In-situ Hybridization (ISH) Market Size by Type (2024-2030)
5.2 United States In-situ Hybridization (ISH) Market Size by Application (2024-2030)
6 Europe
6.1 Europe In-situ Hybridization (ISH) Market Size by Type (2024-2030)
6.2 Europe In-situ Hybridization (ISH) Market Size by Application (2024-2030)
7 China
7.1 China In-situ Hybridization (ISH) Market Size by Type (2024-2030)
7.2 China In-situ Hybridization (ISH) Market Size by Application (2024-2030)
8 Rest of World
8.1 Rest of World In-situ Hybridization (ISH) Market Size by Type (2024-2030)
8.2 Rest of World In-situ Hybridization (ISH) Market Size by Application (2024-2030)
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Key Investors in In-situ Hybridization (ISH)
10.1 Company A
10.1.1 Company A Company Details
10.1.2 Company Description
10.1.3 Companies Invested by Company A
10.1.4 Company A Key Development and Market Layout
10.2 Company B
10.2.1 Company B Company Details
10.2.2 Company Description
10.2.3 Companies Invested by Company B
10.2.4 Company B Key Development and Market Layout
10.3 Company C
10.3.1 Company C Company Details
10.3.2 Company Description
10.3.3 Companies Invested by Company C
10.3.4 Company C Key Development and Market Layout
10.4 Company D
10.5 ……
11 Key Players Analysis
11.1 ABBott Laboratories
11.1.1 ABBott Laboratories Company Details
11.1.2 ABBott Laboratories In-situ Hybridization (ISH) Product Offered
11.1.3 ABBott Laboratories In-situ Hybridization (ISH) Market Size (2024 VS 2030)
11.1.4 ABBott Laboratories Main Business Overview
11.1.5 ABBott Laboratories News
11.2 F.Hoffmann-La Roche
11.2.1 F.Hoffmann-La Roche Company Details
11.2.2 F.Hoffmann-La Roche In-situ Hybridization (ISH) Product Offered
11.2.3 F.Hoffmann-La Roche In-situ Hybridization (ISH) Market Size (2024 VS 2030)
11.2.4 F.Hoffmann-La Roche Main Business Overview
11.2.5 F.Hoffmann-La Roche News
11.3 Thermofisher Scientific
11.3.1 Thermofisher Scientific Company Details
11.3.2 Thermofisher Scientific In-situ Hybridization (ISH) Product Offered
11.3.3 Thermofisher Scientific In-situ Hybridization (ISH) Market Size (2024 VS 2030)
11.3.4 Thermofisher Scientific Main Business Overview
11.3.5 Thermofisher Scientific News
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck In-situ Hybridization (ISH) Product Offered
11.4.3 Merck In-situ Hybridization (ISH) Market Size (2024 VS 2030)
11.4.4 Merck Main Business Overview
11.4.5 Merck News
11.5 Agilent Technologies
11.5.1 Agilent Technologies Company Details
11.5.2 Agilent Technologies In-situ Hybridization (ISH) Product Offered
11.5.3 Agilent Technologies In-situ Hybridization (ISH) Market Size (2024 VS 2030)
11.5.4 Agilent Technologies Main Business Overview
11.5.5 Agilent Technologies News
11.6 Perkin Elmer
11.6.1 Perkin Elmer Company Details
11.6.2 Perkin Elmer In-situ Hybridization (ISH) Product Offered
11.6.3 Perkin Elmer In-situ Hybridization (ISH) Market Size (2024 VS 2030)
11.6.4 Perkin Elmer Main Business Overview
11.6.5 Perkin Elmer News
11.7 Danaher Corporation
11.7.1 Danaher Corporation Company Details
11.7.2 Danaher Corporation In-situ Hybridization (ISH) Product Offered
11.7.3 Danaher Corporation In-situ Hybridization (ISH) Market Size (2024 VS 2030)
11.7.4 Danaher Corporation Main Business Overview
11.7.5 Danaher Corporation News
11.8 Exiqon
11.8.1 Exiqon Company Details
11.8.2 Exiqon In-situ Hybridization (ISH) Product Offered
11.8.3 Exiqon In-situ Hybridization (ISH) Market Size (2024 VS 2030)
11.8.4 Exiqon Main Business Overview
11.8.5 Exiqon News
11.9 Biogenex Laboratories
11.9.1 Biogenex Laboratories Company Details
11.9.2 Biogenex Laboratories In-situ Hybridization (ISH) Product Offered
11.9.3 Biogenex Laboratories In-situ Hybridization (ISH) Market Size (2024 VS 2030)
11.9.4 Biogenex Laboratories Main Business Overview
11.9.5 Biogenex Laboratories News
11.10 Advanced Cell Diagnostics
11.10.1 Advanced Cell Diagnostics Company Details
11.10.2 Advanced Cell Diagnostics In-situ Hybridization (ISH) Product Offered
11.10.3 Advanced Cell Diagnostics In-situ Hybridization (ISH) Market Size (2024 VS 2030)
11.10.4 Advanced Cell Diagnostics Main Business Overview
11.10.5 Advanced Cell Diagnostics News
11.11 Bio SB
12 Research Findings and Conclusion
Ìý
Ìý
*If Applicable.
